How Coca-Cola built the world's most durable beverage franchise

Executive overview

Coca-Cola is the largest consumer staples company by operating profit, yet its reported financials systematically understate value creation. The key is the bottling franchise model: Coke owns the brand, concentrate, and marketing; independent bottlers own the capital-intensive distribution. This split generates ~30% ROIC at the centre versus 10–15% at the bottler level.

A decade of refranchising (2015–2017 peak) has nearly completed the restructuring — margins are rising and alignment between Coke and its bottlers is the strongest it has ever been.

The core insight: Coke is a franchise royalty business masquerading as a beverage company — and its best growth decades may still lie ahead in emerging markets.

The bottling system and why it matters

• Coca-Cola earns a franchise fee (concentrate price) rather than full wholesale revenue — reported revenues are not comparable to peers
• System sales approach $150bn; on that basis Coke generates ~2x Pepsi's operating income in beverages
• Bottlers earn 10–15% ROIC on reported capital; adjusted for intangible franchise rights, cash ROIC is 15–20%+
• Coke retains ~20% equity stakes in most bottlers and board seats — feedback loops drive innovation across the system
• Incidence-based pricing replaced volume-based pricing, aligning both parties around gross profit dollars rather than units
• Concentrate cost as a percentage of bottler sales (~21%) has room to drift higher as markets mature

Competitive advantages

• Distribution network: 30 million customer outlets globally, up 50% over the last decade — no beverage rival is close
• Local bottler partners add go-to-market precision that a global HQ cannot replicate
• Real-time data from SAP/Microsoft Dynamics systems across the bottler network feeds central marketing and category decisions
• Brand equity built over nearly 140 years; "Coca-Cola" is among the most recognised words on earth
• Marketing spend as a percentage of sales dwarfs competitors — 3–5x Pepsi's beverage marketing in absolute terms
• Trademark Coke is a cash cow funding brand acquisition, distribution build-out, and portfolio expansion

Growth drivers

• Volume: unit case volumes have grown ~3% annually for 50–60 years; Coke Zero alone growing 10%+ per year
• Price: ~2–3% annual pricing (roughly inflationary), producing 5–6% system revenue growth — above peer average
• Portfolio cut from 500+ to ~200 brands; remaining non-core brands (Body Armor, Fairlife, Innocent) growing faster than the group
• Coke Zero Sugar and other zero-sugar variants now represent ~35% of volume — structural defence against health concerns
• Alcoholic beverages: Jack & Coke cans, Absolut Vodka & Sprite — early-stage but distribution advantage is enormous
• Costa Coffee: physical stores plus vending rollout; ready-to-drink coffee remains the biggest prize yet to be captured

Emerging market opportunity

• North America (~50% of business) has plateaued on per capita volume but grew again post-pandemic
• Latin America consumption per capita was half North America's 20 years ago; it has since converged toward ~400 servings/year
• Emerging markets currently average ~one-third of Americas per-capita consumption — addressable market could treble
• India remains owned (not yet refranchised) — seen as the single most exciting growth market
• FX has cost 1–2% of organic growth annually for a decade; a weaker dollar era would be a significant tailwind
• 65% of developing-market consumers are not yet in Coke's addressable market versus only 10% in developed markets

Capital allocation

• Moving toward ~$1bn capex once remaining bottling assets (Africa, India, Philippines) are refranchised — currently $7–8bn including those
• 75% of free cash flow paid as dividends (60+ consecutive years of dividend growth)
• ~1% annual share buyback; balance sheet below the 2–2.5x leverage target and deleveraging further
• Acquisitions expected to continue — coffee and adjacent beverage categories most likely
• EBIT margin ~30% today; trending toward 35% on refranchising completion and potentially 50% longer term

Risk: GLP-1 drugs and health trends

• Quantified bear case: ~10% of the US population in a bull scenario for GLP-1 adoption; perhaps a 5% potential volume impact
• Coke has navigated every prior consumer health shift without volume decline — diet variants, zero sugar, and category diversification are the structural response
• Historically, every material threat to volumes (Pepsi wars, diet trends, meal delivery) has not materialised in the unit case data
• Volume growth of 2–4% per year easily offsets a multi-year, gradual demand reduction of that magnitude

Lessons for investors and operators

• Financial statements alone have masked value creation here for 15 years — qualitative analysis of the system was essential to the thesis
• Distribution-backed network effects create a stronger moat than network effects alone
• Franchise/capital-light models only work if there is genuine symbiosis between centre and periphery — financial engineering alone eventually erodes value
• Market-leading positions in consumer brands compound for far longer than consensus expects; returns should not be faded mechanically